VAD
This article presents a succinct but comprehensive expert viewpoint on support in cardiogenic shock using the manuscript of the DanGer trial on promising results of Impella in a highly selected subgroup. With only 360 patients...
This study analyzed 3,394 pediatric congenital heart disease (CHD) patients listed for heart transplant from 2014 to 2023. Of these, 16.5 percent received ventricular assist device (VAD) support while waitlisted....
The opening manuscript on the expected series of American Society of Nuclear Cardiology Imaging Indications. For the cardiovascular surgeon, Tables 2 and 7 offer an update on the use of...
This article presents a succinct but comprehensive expert viewpoint on support in cardiogenic shock using the manuscript of the DanGer trial on promising results of Impella in a highly selected...
This review explores the application of invasive hemodynamic assessments in the personalization of care for patients with left ventricular assist devices (LVADs). The authors provide a comprehensive approach to their...
A somewhat delayed publication of a 2016 paper that discusses important trends in cardiac transplanation in the light of increasing use of ECMO.
...Gosev and colleagues evaluated the baseline characteristics and outcomes in 156 patients from 12 centers who survived at least four years on left ventricular assist device (LVAD) support. Among this...
An interesting two-year report from the MOMENTUM 3 randomized controlled trial comparison of HeartMate 3 and II, the analysis performed by Abbott. Although stroke and reoperation were clearly lower with...
Schweiger and colleagues retrospectively analyzed stroke rate for patients under 19 years old in the European Registry for Patients with Mechanical Circulatory Support database. Analysis of the 51 pediatric patients...
A sobering editorial, read last May at the AATS, that discusses at length the ethics of ventricular assist as a super expensive therapy seen from the principle of fairness.
...Bansal and colleagues describe survival after left ventricular assist device placement for patients with end-stage renal disease (ESRD), based on Medicare claims associated with data in the United States Renal...
The incoming issue of the Journal comes with an interesting group of papers revolving around a provocative topic: work from Seattle on the absence of predictive value of standard pulmonary...
A measured succinct reflection on MagLev and older ventricular assist devices, on the occasion of a relevant ‘expert opinion’ paper on the topic.
...

